지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
초록· 키워드
오류제보하기
.
목차
등록된 정보가 없습니다.
참고문헌 (26)
참고문헌 신청
World Health Organization / Hepatitis B. Fact Sheet No. 204
NCBI / Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Sarin SK / 2016 / Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update / Hepatol Int 10(1):1~98
Ott JJ / 2012 / Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity / Vaccine 30(12):2212~2219
Lozano R / 2012 / Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 / Lancet 380(9859):2095~2128
NCBI / Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
Sarin SK / 2016 / Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update / Hepatol Int 10(1):1~98
Ott JJ / 2012 / Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity / Vaccine 30(12):2212~2219
Lozano R / 2012 / Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 / Lancet 380(9859):2095~2128
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?
Clinical and Molecular Hepatology
2020 .01
-
The Epidemiology of Hepatitis B Virus Infection in Korea: 15-Year Analysis
Journal of Korean Medical Science
2024 .01
-
Renal Function between Tenofovir and Entecavir in Post-Liver Transplant Hepatitis B Patients
대한외과학회 학술대회 초록집
2018 .11
-
Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)idenaïve patients
Clinical and Molecular Hepatology
2017 .01
-
Drug-drug interactions with direct-acting antivirals ? less is more
Clinical and Molecular Hepatology
2021 .01
-
Unmet need in chronic hepatitis B management
Clinical and Molecular Hepatology
2019 .01
-
Direct-Acting Antiviral Therapy and Risk of Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C
Gut and Liver
2021 .01
-
Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
Gut and Liver
2016 .01
-
A severe case of tenofovir-associated acute kidney injury requiring hemodialysis in a patient with chronic hepatitis B
Kidney Research and Clinical Practice
2020 .01
-
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop
Clinical and Molecular Hepatology
2020 .01
-
Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
Gut and Liver
2016 .01
-
Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis
Gut and Liver
2020 .01
-
Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles
Clinical and Molecular Hepatology
2022 .04
-
The efficacy of Tenofovir-based therapy in patients showing suboptimal response to Entecavir-Adefovr combination therapy
Clinical and Molecular Hepatology
2016 .01
-
Risk score model for the development of hepatocellular carcinoma in treatment-naive patients receiving oral antiviral treatment for chronic hepatitis B
Clinical and Molecular Hepatology
2017 .06
-
The best predictive model for hepatocellular carcinoma in patients with chronic hepatitis B infection
Clinical and Molecular Hepatology
2022 .07
-
The factor that improve liver stiffness in patients with chronic hepatitis B
Clinical and Molecular Hepatology
2015 .01
-
Overview of anti-Hepatitis B virus agents
JOURNAL OF BACTERIOLOGY AND VIROLOGY
2020 .09
-
Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
Gut and Liver
2024 .03
-
What is the Long-term Benefit of Direct-acting Antiviral Therapy in Chronic Hepatitis C?
Journal of Korean Medical Science
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0